Analysis of recurrence trends according to risk groups after renal cancer nephrectomy

被引:1
作者
Polanco Pujol, L. [1 ]
Herranz Amo, F. [1 ]
Cano Velasco, J. [1 ]
Moralejo Garate, M. [1 ]
Subira Rios, D. [1 ]
Barbas Bernardos, G. [1 ]
Mayor de Castro, J. [1 ]
Aragon Chamizo, J. [1 ]
Husilllos Alonso, A. [1 ]
Hernandez Fernandez, C. [1 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Urol, Madrid, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2020年 / 44卷 / 08期
关键词
Renal cancer; Recurrence; Recurrence-free survival; CELL CARCINOMA; ONCOLOGIC OUTCOMES; SURVEILLANCE; PROGNOSIS; DISEASE;
D O I
10.1016/j.acuro.2020.03.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Recurrence trends after renal cell cancer nephrectomy are not clearly defined. Objective: To evaluate recurrence trends according to recurrence risk groups (RRG). Material and method: Retrospective analysis of 696 patients with renal cell cancer treated with nephrectomy between 1990-2010. Three RRG were defined according to the presence of anatomopathological variables (pTpN stage, nuclear grade, tumor necrosis [TN], sarcomatoid differentiation [SD], positive resection margin [RM]): Low RG (LRG): pT1pNx-0 G1-4, pT2pNx-0 G1-2; no TN, SD and/or RM (+). Intermediate RG (IRG): pT2pNx-0 G3-4; pT3-4pNx-0 G1-2; LRG with TN. High RG (HRG): pT3-4pNx-0 G3-4; pT1-4pN +; IRG with TN and/or SD; LRG with SD and/or RM (+). The Kaplan-Meier method has been used to evaluate recurrence-free survival as a function of RRG. The log-rank test was used to evaluate differences between survival curves. Results: The median follow-up was 105 (IQR 63-148) months. Of the total series, 177 (25.4%) patients presented recurrence: distant 15.9%, local 4.9% and 4.6% distant and local. The recurrence rate varied according to the RRG with values of 72.9% for HRG, 16.9% for IRG and 10.2% for LRG (p =.0001). Most cases in LRG presented single organ recurrence (72.2%) (p=.006). The LRG experienced recurrence as single metastasis in 50% of cases, compared to 30% and 18.6% in IRG and HRG, respectively (p=.009). The most common sites of recurrence were lung and abdomen. Lung recurrence predominated in the HRG (72.9%) (p =.0001) and abdominal, in the LRG (83.3%) with a tendency to significance (p=.15). Conclusions: Recurrence rates (especially bone and lung) increase with higher RG. Single organ recurrences and single metastases are more frequent in LRG. (C) 2020 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:554 / 560
页数:7
相关论文
共 50 条
  • [31] Esophageal metastasis of renal cancer 10 years after nephrectomy
    Wataru Izumo
    Masaho Ota
    Kosuke Narumiya
    Yushi Shirai
    Kenji Kudo
    Masakazu Yamamoto
    Esophagus, 2015, 12 : 91 - 94
  • [32] Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification
    Siegenthaler, F.
    Lindemann, K.
    Epstein, E.
    Rau, T. T.
    Nastic, D.
    Ghaderi, M.
    Rydberg, F.
    Mueller, M. D.
    Carlson, J.
    Imboden, S.
    GYNECOLOGIC ONCOLOGY, 2022, 165 (02) : 230 - 238
  • [33] Analysis of features of recurrence after radical nephrectomy in patients with N0M0 renal cell carcinoma
    Onishi T.
    Oishi Y.
    Yamazaki H.
    Furuta N.
    Asano K.
    International Journal of Clinical Oncology, 2000, 5 (5) : 297 - 302
  • [34] Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer
    Forbes, Connor M.
    Rendon, Ricardo A.
    Finelli, Antonio
    Kapoor, Anil
    Moore, Ronald B.
    Breau, Rodney H.
    Lacombe, Louis
    Kawakami, Jun
    Drachenberg, Darrel E.
    Pautler, Stephen E.
    Jewett, Michael M. A.
    Saarela, Olli
    Liu, Zhihui
    Tanguay, Simon
    Black, Peter C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) : 486.e17 - 486.e23
  • [35] The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy
    Capogrosso, Paolo
    Larcher, Alessandro
    Nini, Alessandro
    Muttin, Fabio
    Cianflone, Francesco
    Ripa, Francesco
    Briganti, Alberto
    Necchi, Andrea
    Montorsi, Francesco
    Salonia, Andrea
    Bertini, Roberto
    Capitanio, Umberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (04) : 293.e25 - 293.e30
  • [36] Risk models for recurrence and survival after kidney cancer: a systematic review
    Usher-Smith, Juliet A.
    Li, Lanxin
    Roberts, Lydia
    Harrison, Hannah
    Rossi, Sabrina H.
    Sharp, Stephen J.
    Coupland, Carol
    Hippisley-Cox, Julia
    Griffin, Simon J.
    Klatte, Tobias
    Stewart, Grant D.
    BJU INTERNATIONAL, 2022, 130 (05) : 562 - 579
  • [37] Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma
    Schmid, Marianne
    Krishna, Nandita
    Ravi, Praful
    Meyer, Christian P.
    Becker, Andreas
    Dalela, Deepansh
    Sood, Akshay
    Chun, Felix K. -H.
    Kibel, Adam S.
    Menon, Mani
    Fisch, Margit
    Trinh, Quoc-Dien
    Sun, Maxine
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (07) : 293.e1 - 293.e10
  • [38] Long-term outcomes of radiofrequency ablation vs. partial nephrectomy for cT1 renal cancer: A meta-analysis and systematic review
    Li, Linjin
    Zhu, Jianlong
    Shao, Huan
    Huang, Laijian
    Wang, Xiaoting
    Bao, Wenshuo
    Sheng, Tao
    Chen, Dake
    He, Yanmei
    Song, Baolin
    FRONTIERS IN SURGERY, 2023, 9
  • [39] Outcomes and Clinicopathologic Variables Associated With Late Recurrence After Nephrectomy for Localized Renal Cell Carcinoma
    Kim, Simon P.
    Weight, Christopher J.
    Leibovich, Bradley C.
    Thompson, R. Houston
    Costello, Brian A.
    Cheville, John C.
    Lohse, Christine M.
    Boorjian, Stephen A.
    UROLOGY, 2011, 78 (05) : 1101 - 1106
  • [40] Cystic local recurrence of renal cell carcinoma after laparoscopic radical nephrectomy in a hemodialysis patient
    Ito, Kazuyo
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kobayashi, Hirohito
    Tomita, Eri
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (03) : 330 - 332